Malaysia’s position as one of Southeast Asia’s leading destinations for health care tourism – illustrated by its 1.85 million health care travellers generating a record RM3.35 billion in revenue in 2025 – is well-established.
By any conventional measure, the industry is a hale and hearty one. Malaysia’s confidence is such that 2026 has been declared the Malaysia Year of Medical Tourism, an explicit attempt to accelerate this growth further.
Much of this success can be attributed to Malaysia’s carefully curated position in the region: it offers patients from neighbouring countries access to an extensive private health care network with specialised care while remaining more affordable than Singapore, just across the Causeway.
As propositions go, it is a fairly compelling one. Little wonder, then, that Malaysia’s private health care sector is expanding its capacity in anticipation of further growth.
And yet, it is entirely possible for us to attract more medical tourists while simultaneously diminishing the very foundations that brought us here – a path that potentially ends in us becoming medical tourists ourselves.
The risk lies in assuming that aggressive expansion will continue to drive Malaysia’s success in this sector, and that expansion, in and of itself, will preserve the conditions that made it an attractive proposition to begin with.
But capacity is not the same as capability. We may add beds, clinics, and operating theatres, expanding our ability to receive and treat more patients. But equally, we must develop specialised expertise, adopt advanced technology, and invest in the institutional depth that informs patients which borders are worth crossing in their search for care.
Malaysia’s private health care sector may thus continue growing in physical size, even as the key attributes that underpinned that growth gradually diminish.
This is where the threads of my previous essays – on the false economy of pursuing the cheapest bill, on the commoditisation of our health care, and on the true cost of being the last to adopt – converge.
When cost containment erodes differentiation, hospitals become interchangeable. When investment in technology becomes increasingly difficult to justify, the features and capabilities that distinguish one health care provider from another gradually disappear.
Neither of these processes necessarily results in an immediate drop in patient volume. Existing reputation, proximity, and affordability may continue to sustain growth in the short term. But these attributes cannot substitute for capability, certainly not indefinitely. And this distinction is especially crucial as those around us are not standing still.
Indonesia, whose health care travellers account for 65.8 per cent of our medical tourism revenue, is actively trying to stem the flow. The Sanur Health Special Economic Zone, anchored by Bali International Hospital, is just one example of the Indonesian government’s strategy to reduce outbound treatment and its associated loss of foreign exchange.
Crucially, it is seeking to establish both the incentives and the capability – not mere capacity – to reproduce at home the very characteristics that have so often drawn its patients across our borders.
To our north, one of our principal regional competitors, Thailand, is strengthening its own proposition. The Medical Hub strategy represents an ambitious ten-year framework that encompasses medical innovation, specialised expertise, international partnerships, and end-to-end health care services as its foundation.
As with Indonesia, additional facilities form only part of the plan – the overarching aim is to deepen the ecosystem that supports them.
Malaysia thus risks being squeezed on both sides: its largest market is working to give its patients fewer reasons to leave, all while its principal competitor is creating more reasons for international patients to go elsewhere.
Malaysia, to its credit, is not idle. Private health care providers continue to expand their networks, develop centres of excellence, invest in advanced equipment and technology, and improve the overall experience. These efforts deserve recognition. But their success – and the sector’s – cannot be taken for granted.
It is here that the potential consequences highlighted in my previous essays begin to materialise.
If blunt and overly restrictive measures are imposed in the name of financial prudence, we risk hampering our ability to develop and extend our health care capabilities. Over the long term, we may then lose the very factors that made Malaysia an attractive destination in the first place.
As our capabilities diminish and complex cases migrate elsewhere, we may lose not only revenue, but also the clinical volume and experience through which expertise is built. Further investment then becomes harder to justify, leaving our clinicians with fewer opportunities to develop and prompting still more patients to cast their gaze abroad.
What begins as an exercise in controlling bill sizes can thus snowball into a self-reinforcing loss of capability.
For Malaysians with the means to travel, seeking treatment abroad becomes an entirely rational option. They do not need to conclude that the Malaysian health care system is poor, only that, for their particular condition, better care is available elsewhere. Those able to cross borders will do so. Those unable to do so will inherit whatever capability remains.
It must be stressed, as I have before, that none of this is an argument against cost discipline. Waste, unwarranted variation, and excess must be identified and addressed continuously. Indeed, one may argue that this is long overdue.
But when cost control veers from prudence into austerity, it threatens more than the options available to individual patients. In the long run, it threatens the institutional expertise, the technological capabilities, and the very clinical ecosystem upon which our position as a health care destination depends.
Malaysia can become a country of medical tourists without ceasing to be a destination for medical tourism. These two processes are not mutually exclusive: foreign patients may continue arriving for care we provide well and affordably, even as Malaysians leave in search of capabilities we have made progressively harder to build and retain.
If it is only when the headline figures begin to shift that we ask what kind of country we want to be – and what kind of health care system we wish to have – we may find that our choices have already been constrained by the capabilities we allowed to erode.
Dr Ng Kuo Chern is a medical doctor with an MBA and works in hospital operations, where he is involved in service delivery, organisational improvement, and value-driven outcomes. He writes on health care systems, economics, and policy in his personal capacity.
- This is the personal opinion of the writer or publication and does not necessarily represent the views of CodeBlue.
